During the past decade, Contact CSL Behring for facility details conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Contact CSL Behring for facility details" are "Agammaglobulinemia" (1 trials), "Common Variable Immunodeficiency" (1 trials), "Fibrinogen Deficiency" (1 trials), "Hereditary Angioedema" (1 trials) and "IgG Deficiency" (1 trials). Many other conditions were trialed in "Contact CSL Behring for facility details" in a lesser frequency.

Most popular intervention types in "Contact CSL Behring for facility details" are "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "C1 Esterase Inhibitor" (1 trials), "Human Fibrinogen Concentrate" (1 trials), "IgPro20" (1 trials) and "Immunoglobulins Intravenous (Human)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Contact CSL Behring for facility details" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Contact CSL Behring for facility details". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Contact CSL Behring for facility details, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Contact CSL Behring for facility details, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".